Enovis Corp
NYSE:ENOV
Enovis Corp
Cash from Operating Activities
Enovis Corp
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Enovis Corp
NYSE:ENOV
|
Cash from Operating Activities
$135m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Enovis Corp's Cash from Operating Activities?
Cash from Operating Activities
135m
USD
Based on the financial report for Dec 31, 2023, Enovis Corp's Cash from Operating Activities amounts to 135m USD.
What is Enovis Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-10%
The average annual Cash from Operating Activities growth rates for Enovis Corp have been -24% over the past three years , -10% over the past five years .